Writing
Notes for sponsors and operators on the hold
We publish checklists, cost guides and diligence notes several times a week.
Understanding the 'Y Rule of Retirement': Challenges and Strategies for Men in Financial Planning
Discover the Y Rule of Retirement, addressing men's unique financial challenges and health impacts. Plan intentionally for a secure future.
Financial Freedom at 40: A Personal Journey to Early Retirement
Discover strategies for achieving early retirement, even if you feel financially behind. Take actionable steps toward financial freedom today!
Unlocking Growth Potential: Analyzing Laureate Education's Market Position and Future Prospects
Explore Laureate Education's potential with insights on growth drivers, financial health, and a promising 29.1% upside. Click to learn more!
ALBIS Leasing: A Financial Overview of Resilience and Growth
Discover how ALBIS Leasing achieves 39% EPS growth and strong EBIT margins. Explore insights on technology, insider ownership, and industry trends.
The Impact of AI on the Job Market: A Modern Crisis
Explore how AI is reshaping the job market, affecting industries and creativity, and learn strategies to adapt to this new landscape.
European Economic Resilience: Eurobonds as a Catalyst for Growth Amid Global Uncertainty
Discover how eurobonds could reshape Europe's economy, enabling smarter investments and overcoming historical challenges. Learn more!
Understanding the Challenges Facing Hong Kong's Property Market: A New Kind of Slump
Explore the current downturn in Hong Kong's property market, its unique challenges, and future implications for investors. Discover insights for navigating change.
Corporate Buybacks Surge: What This Means for Investors and Market Stability
Explore the implications of corporate buybacks on stock prices and dividends. Understand trends and strategies investors need to consider.
Iovance Biotherapeutics Faces Investor Concerns Amidst Soaring Revenue Growth
Discover Iovance Biotherapeutics' explosive revenue growth and the challenges it faces in the biotech sector. Explore insights on its future strategies!
Novo Nordisk's Stock Rally Amid Rival's Mixed Clinical Trial Results
Explore GLP-1 weight loss drugs, comparing Novo Nordisk's Wegovy and Eli Lilly's orforglipron. Discover insights into effectiveness and market dynamics!
The weekly briefing
Growth Shuttle Insider
A weekly email on how value is built in private equity and mid-market companies, written by someone who does the work. There is no fund or deal behind it.
- 29,000+ operators and investors
- Weekly in your inbox
- Free and always will be